Skip to main content
Equibles

Caligan Partners LP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1727492 NEW YORK, NY
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,995,951
+$186,566 QoQ
Shares Held
1,435,130
0.0% QoQ
Ownership
10.7%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#2
of 134 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Caligan Partners LP holds $668,315,210 across 2 Drug Manufacturers - Specialty & Generic names. ANIK ranks #2 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 8,118,892 $647,319,259
2 ANIK
Anika Therapeutics, Inc.
This page 		1,435,130 $20,995,951

All Filings in ANIK

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,995,951 1,435,130
2026-03-31 $20,809,385 1,435,130
2025-12-31 $13,791,599 1,435,130
2025-09-30 $13,490,222 1,435,130
2025-06-30 $15,183,675 1,435,130
2025-03-31 $21,570,003 1,435,130
2024-12-31 $23,622,239 1,435,130
2024-09-30 $35,447,711 1,435,130
2024-06-30 $36,373,702 1,435,993
2024-03-31 $36,474,222 1,435,993
2023-12-31 $24,503,617 1,081,360
2023-09-30 $20,145,736 1,081,360
2023-06-30 $18,713,160 720,291
2023-03-31 $20,543,157 715,291
2022-12-31 $17,513,580 591,675